Opko Health (OPK) Cash from Investing Activities (2010 - 2026)

Opko Health has reported Cash from Investing Activities for 17 years, with the latest figure at -$1.8 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities fell 104.44% year-over-year to -$1.8 million; the trailing twelve-month figure through Mar 2026 stood at $188.0 million (down 27.93% YoY), and the FY2025 full-year result was $230.3 million, down 34.61% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$1.8 million, up from -$2.0 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $236.2 million in Q3 2024, with the low at -$11.6 million in Q2 2024.
• Historically, Cash from Investing Activities has averaged $32.6 million across 5 years, with a median of -$3.2 million in 2023.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities slumped 343.31% — and 2024, when it soared 6713.3%.
• Opko Health's Cash from Investing Activities stood at -$7.9 million in 2022, then surged by 81.99% to -$1.4 million in 2023, then soared by 16759.17% to $236.2 million in 2024, then slumped by 100.87% to -$2.0 million in 2025, then increased by 12.02% to -$1.8 million in 2026.
• The last three Cash from Investing Activities figures came in at -$1.8 million (Q1 2026), -$2.0 million (Q4 2025), and $194.6 million (Q3 2025), per Business Quant data.